Abstracts tagged "Knee"

Abstract Number: 1208 • 2017 ACR/ARHP Annual Meeting
Levels of Serum Biomarkers from a Two-Year Multicentre Trial Are Associated with Treatment Response on Knee Osteoarthritis Cartilage Loss As Assessed By MRI: An Exploratory Study
Johanne Martel-Pelletier¹, Jean-Pierre Raynauld¹, François Mineau¹, François Abram², Patrice Paiement³, Philippe Delorme³ and Jean-Pierre Pelletier¹, ¹Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, ²Medical Imaging Research & Development, ArthroLab Inc., Montreal, QC, Canada, ³ArthroLab Inc., Montreal, QC, Canada
Background/Purpose: There is an obvious need to identify biomarkers that could predict patient response to an osteoarthritis (OA) treatment. This post hoc study explored in…
Abstract Number: 2767 • 2017 ACR/ARHP Annual Meeting
Active Yet Sedentary: The Association of Moderate to Vigorous Physical Activity and Sedentary Behavior with Incident Functional Limitation in Knee OA
Hiral Master¹, Louise Thoma¹, Meredith Christiansen¹, Dana Mathews² and Daniel White³, ¹Physical Therapy and Biomechanics and Movement Science, University of Delaware, Newark, DE, ²Physical Therapy, Biomechanics and Movement Science, University of Delaware, Newark, DE, ³Department of Physical Therapy, University of Delaware, Newark, DE
Background/Purpose: Engaging in adequate levels of moderate to vigorous physical activity (MVPA) reduces the risk of functional limitation in people with knee osteoarthritis (OA). Sedentary…
Abstract Number: 980 • 2017 ACR/ARHP Annual Meeting
Is Intra-Articular Injection of Synvisc Associated with a Delay to Knee Arthroplasty in Knee OA Patients?
Kevin Ong¹, Maria Runa¹, Edmund Lau² and Roy Altman³, ¹Exponent, Inc., Philadelphia, PA, ²Exponent, Inc., Menlo Park, CA, ³UCLA Medical Center, Los Angeles, CA
Background/Purpose: Knee OA patients may undergo intra-articular (IA) hyaluronic acid (HA) injection treatment, but there is debate about its effectiveness. We asked: (1) What is…
Abstract Number: 1788 • 2017 ACR/ARHP Annual Meeting
Dose Intra-Articular Injection of Corticosteroids Increase the Risk of Knee Osteoarthritis Progression? Data from the Osteoarthritis Initiative
Guang-hua Lei¹, Chao Zeng¹, Jie Wei^2,3, Yi-lun Wang¹ and Dong-xing Xie¹, ¹Department of orthopaedics, Xiangya Hospital, Central South University, Changsha, China, ²Health Management Center, Xiangya Hospital, Central South University, Changsha, China, ³Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China
Background/Purpose: Although intra-articular injection of corticosteroids (IAIC) has been one of the modalities of treatment for symptomatic knee OA, the recommendations for its use are…
Abstract Number: 2793 • 2017 ACR/ARHP Annual Meeting
Joint Location-Specific JAK-STAT Signaling in Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes (FLS)
Deepa Hammaker¹, Gyrid Nygaard¹, David L. Boyle², Rizi Ai³, Wei Wang⁴ and Gary S. Firestein⁵, ¹Medicine, UC San Diego, La Jolla, CA, ²University of California San Diego, La Jolla, CA, ³UC San Diego, La Jolla, CA, ⁴Chemistry and Biochemistry, UC San Diego, La Jolla, CA, ⁵Medicine, University of California San Diego, La Jolla, CA
Background/Purpose: Aberrant epigenetic marks in RA FLS contribute to disease pathogenesis and aggressive FLS behavior. Computational data also suggest that RA FLS isolated from different…
Abstract Number: 1006 • 2017 ACR/ARHP Annual Meeting
Sex Differences in Depressive Symptom Subtypes in Knee Osteoarthritis
Alan Rathbun¹, Megan Schuler², Elizabeth Stuart³, Michelle Shardell⁴, Michelle S. Yau⁵ and Marc Hochberg⁶, ¹Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, ²Rand Coportation, Boston, MA, ³Mental Health, Biostatistics, and Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, ⁴Translational Gerontology Branch, National Institute on Aging, Baltimore, MD, ⁵Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, ⁶Department of Medicine, University of Maryland School of Medicine, Baltimore, MD
Background/Purpose: Knee osteoarthritis (OA) is characterized by structural changes in subchondral bone and degradation of articular cartilage, but the pathology does not necessarily lead to…
Abstract Number: 1853 • 2017 ACR/ARHP Annual Meeting
Exercise and Adherence over Two Years: Beliefs of Adults with Knee Osteoarthritis
Aileen Ledingham¹, Ellen Cohn², Kristin Baker³ and Julie Keysor¹, ¹Physical Therapy, Boston University, Boston, MA, ²Occupational Therapy, Boston University, Boston, MA, ³Physical Therapy, Boston University Sargent College, Boston, MA
Background/Purpose: Exercise is an established treatment to improve pain and physical function in adults with knee osteoarthritis (KOA), which is a leading cause of disability…
Abstract Number: 2823 • 2017 ACR/ARHP Annual Meeting
Preliminary Comparison of Patient-Centered Weight Loss Programs Starting before Versus after Knee Replacement
Christine Pellegrini^1,2, Rowland W. Chang³, Dorothy D. Dunlop⁴, David Conroy^1,5, Julia (Jungwha) Lee⁶, Linda VanHorn⁶, Bonnie Spring¹ and Kenzie Cameron⁷, ¹Northwestern University Feinberg School of Medicine, Chicago, IL, ²Exercise Science, University of South Carolina's Arnold School of Public Health, Columbia, SC, ³Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁴Center for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁵Kinesiology, The Pennsylvania State University, University Park, PA, ⁶Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁷General Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Background/Purpose: Most patients risk gaining weight in the years after knee replacement, adding further concern to a population that is mostly overweight/obese prior to surgery.…
Abstract Number: 1029 • 2017 ACR/ARHP Annual Meeting
What to Measure after Arthroplasty? Confirmation of a Core Domain Set
Anh Hoang¹, Susan M. Goodman², Mark P. Figgie³, Mathias Bostrom⁴, Douglas Padgett⁴, Lisa A. Mandl^5,6,7, Peter Sculco⁸, Alexander McLawhorn⁹ and Jasvinder A. Singh¹⁰, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Medicine, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ³Orthopaedic Surgery, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ⁴Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, ⁵Department of Medicine, Hospital for Special Surgery, New York, NY, ⁶Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ⁷Department of Rheumatology, Hospital for Special Surgery, New York, NY, ⁸Orthopaedic Surgery, Hospital for Special Surgey, New York, NY, ⁹Hospital for Special Surgey, New York, NY, ¹⁰Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: The Outcomes Measures in Rheumatology Trials (OMERACT) TJR Working Group has proposed six core domains that would constitute a standardized measurement set that can…
Abstract Number: 2019 • 2017 ACR/ARHP Annual Meeting
Structural Abnormalities in the Knee Detected By MRI in Middle-Aged Subjects without Radiographic Knee Osteoarthritis
Jaanika Kumm¹, Aleksandra Turkiewicz², Fan Zhang² and Martin Englund², ¹Department of Radiology, University of Tartu, Tartu, Estonia, ²Clinical Sciences Lund, Orthopedics, Clinical Epidemiology Unit, Lund University, Lund, Sweden
Background/Purpose: Early OA is a complex, poorly understood and still largely an unchartered “entity”. Thus, our purpose was evaluate the prevalence of findings suggestive of…
Abstract Number: 2835 • 2017 ACR/ARHP Annual Meeting
5-Year Evolution Patterns of Physical Activity and Sedentary Behavior of Patients with Symptomatic Hip and/or Knee Osteoarthritis, and Their Sociodemographic and Clinical Correlates
Sarah Bitar¹, Abdou Y Omourou^2,3, Aurélie Van-hoye¹, Francis Guillemin^4,5 and Anne-Christine Rat^4,5,6, ¹Université de Lorraine, EA 4360 APEMAC, Nancy, France, ²Université de lorraine, EA 4360 APEMAC, Nancy, France, ³Inserm, CIC-1433 Clinical epidemiology, Nancy, France, ⁴Université de Lorraine, EA4360, APEMAC, Nancy, France, ⁵Inserm, CIC-1433 Epidémiologie Clinique, Vandoeuvre-lès-Nancy, France, ⁶Rheumatology Department, CHRU Nancy, Vandoeuvre-lès-Nancy, France
Background/Purpose: Regular Physical Activity (PA) at a moderate level of intensity for approximately 2.5 hours per week is recommended in the management of hip and/or…
Abstract Number: 1043 • 2017 ACR/ARHP Annual Meeting
Comparison of the Costs for Hyaluronic Acid and Total Knee Arthroplasty in the Treatment of OA for the Blue Cross/Blue Shield Patient Population
Kevin Ong¹, Faizan Niazi², Edmund Lau³, Peter Shaw² and Steven Kurtz¹, ¹Exponent, Inc., Philadelphia, PA, ²Ferring Pharmaceuticals, Inc., Parsippany, NJ, ³Exponent, Inc., Menlo Park, CA
Background/Purpose: Previous HA studies have focused on the Medicare population, but less is known of the treatment patterns and cost of HA relative to knee…
Abstract Number: 2178 • 2017 ACR/ARHP Annual Meeting
Metabolic Osteoarthritis: Relation of Cardiovascular Disease and Diabetes to Knee Osteoarthritis
Laura Kuusalo¹, David T. Felson², Carrie Brown³, Cora E. Lewis⁴, James Torner⁵ and Tuhina Neogi², ¹University of Turku and Turku University Hospital, Turku, Finland, ²Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ³Boston University School of Public Health, Boston, MA, ⁴University of Alabama Birmingham, Birmingham, AL, ⁵University of Iowa, Iowa City, IA
Background/Purpose: Metabolic changes or low-grade inflammation related to cardiovascular disease (CVD) and diabetes have been hypothesized to contribute to the development of OA. Prior studies…
Abstract Number: 2852 • 2017 ACR/ARHP Annual Meeting
Widespread Pain Prior to Total Knee Replacement (TKR) Is Associated with Increased Risk of No Clinical Improvement in Pain Among Women
Ernest Vina¹, Di Ran², Erin L. Ashbeck² and C. Kent Kwoh³, ¹Rheumatology, University of Arizona, Tucson, AZ, ²The University of Arizona Arthritis Center, Tucson, AZ, ³University of Arizona, Tucson, AZ
Background/Purpose: Up to 47% of individuals may not have clinically significant improvement following joint replacement surgery. Evidence also suggests that women are less likely to…
Abstract Number: 1050 • 2017 ACR/ARHP Annual Meeting
Prevalence and Predictors of Knee Replacement Overuse and Underuse in the US
Hassan Ghomrawi¹, Alvin Mushlin², Raymond Kang³, Samprit Banerjee², Jasvinder A. Singh⁴, Leena Sharma⁵, Tuhina Neogi⁶, Michael C. Nevitt⁷ and Daniel Riddle⁸, ¹Surgery and Pediatrics/Center for Healthcare Studies, Feinberg School of Medicine of Northwestern University, Chicago, IL, ²Healthcare Policy and Research, Weill Cornell Medical College, New York, NY, ³Center for Healthcare Studies, Feinberg School of Medicine of Northwestern University, Chicago, IL, ⁴Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁵Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁶Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ⁷Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, ⁸Virginia Commonwealth University, Richmond, VA
Background/Purpose: The elective nature of knee replacement (KR) creates difficult decisions and the potential for both overuse and underuse. We examined the temporal relationship between…

« Previous Page
1
…
4
5
6
7
8
…
24
Next Page »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.